29th September, 2016

Chris Bender, director of regulatory advisory at Chatham Financial, looks at the progress and remaining obstacles towards achieving a cohesive harmonious cross-border OTC derivatives regulatory framework
Go beyond this article with 1 month’s free, no obligation access to FOW Intelligence — bringing you expert insights and analysis backed by our comprehensive volumes database. Everything you need to stay informed and make smarter decisions.
